Schwab US Large Cap Growth ETF vs Verisign, Inc. — how do they compare? Schwab US Large Cap Growth ETF trades at $36.75 (market cap $65.01B), while Verisign, Inc. trades at $304.06 (market cap $26.92B). The key difference: Schwab US Large Cap Growth ETF is far larger — about 2.4× Verisign, Inc.'s market cap, and Verisign, Inc. pays a 1.09% dividend while Schwab US Large Cap Growth ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Schwab US Large Cap Growth ETF for 50 Days and Verisign, Inc. for 123 Days on average.
| SCHG | VRSN | |
|---|---|---|
Market Cap | $65.01B | $26.92B |
Volume | 8,554,399 | 1,921,402 |
Sector | Sector/Thematic | Technology |
52-Week High | $36.93 | $310.00 |
52-Week Low | $28.10 | $211.49 |
Typical Hold Time | 50 Days | 123 Days |
Enterprise Value | — | $28.23B |
Dividend Yield | — | 1.09% |
Signals from Pluang's Aura AI — not financial advice
SCHG trades at $36.74, down 0.35% on the day, with a bullish technical signal from moving averages and neutral oscillators. The ETF maintains strong institutional interest despite a recent position reduction by Corient Private Wealth. Recent news highlights SCHG's low 0.03% expense ratio and its focus on large-cap growth stocks, though concentration in top holdings remains a structural consideration.
The outlook for SCHG remains positive given its growth orientation and cost efficiency, though investors should monitor concentration risks in top holdings. Market leadership in growth sectors and competitive fees support long-term potential, while sensitivity to tech sector volatility presents the primary near-term risk.
VeriSign (VRSN) trades at $303.74, up 3.24% today, with a bullish technical outlook supported by moving averages. The stock shows strong profitability with a 49.77% net income margin and consistent revenue growth, reaching $1.66B in 2025. Recent news includes an upcoming Q3 2026 earnings call and insider selling by the CEO, while institutional buying from firms like BlackRock signals confidence. A class-action antitrust lawsuit filed in September 2026 poses a regulatory risk.
The investment outlook is positive, driven by analyst consensus favoring a buy rating with a $348 price target, implying 15% upside. Key opportunities include AI-driven domain growth and a pending .com price increase. Risks involve the antitrust litigation, competitive pressures, and reliance on domain registry revenues. Earnings momentum is mixed, with Q2 2026 missing estimates but Q1 beating expectations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →Verisign is the sole authorized registry for several generic top-level domains, including the widely utilized .com and .net top-level domains. The company operates critical Internet infrastructure to support the domain name system, including operating two of the world's 13 root servers that are used to route Internet traffic. In 2018, the firm sold off its Security Services business, signalling a renewed focus on the core registry business.
Read more on VRSN →